REVIEW Nongenomic Signaling Pathways of Estrogen Toxicity
暂无分享,去创建一个
[1] J. Adams. Human breast cancer: Concerted role of diet, prolactin and adrenal C19‐Δ5‐steroids in tumorigenesis , 1992, International journal of cancer.
[2] M. Nevalainen,et al. Prolactin and prolactin receptors are expressed and functioning in human prostate. , 1997, The Journal of clinical investigation.
[3] P. Dannies. CHAPTER 9 – Control of Prolactin Production by Estrogen , 1985 .
[4] T. Midoro-Horiuti,et al. Environmental Estrogens Induce Mast Cell Degranulation and Enhance IgE-Mediated Release of Allergic Mediators , 2006, Environmental Health Perspectives.
[5] C. Watson,et al. Regulation of the membrane estrogen receptor‐α: role of cell density, serum, cell passage number, and estradiol , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] T. van Amelsvoort,et al. Mood, cognition and Alzheimer's disease. , 2002, Best practice & research. Clinical obstetrics & gynaecology.
[7] L. Sobrinho. Prolactin, Psychological Stress and Environment in Humans: Adaptation and Maladaptation , 2004, Pituitary.
[8] R. Holmdahl,et al. Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. , 2001, Arthritis and rheumatism.
[9] T. Pappas,et al. Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α , 1999, Steroids.
[10] Edward J. Filardo,et al. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release , 2005, Trends in Endocrinology & Metabolism.
[11] U. Meinhardt,et al. The Essential Role of the Aromatase/P450arom , 2002, Seminars in reproductive medicine.
[12] M. von Zastrow,et al. Regulated Endocytosis of G-protein-coupled Receptors by a Biochemically and Functionally Distinct Subpopulation of Clathrin-coated Pits* , 1998, The Journal of Biological Chemistry.
[13] C. Watson,et al. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways , 2004, Steroids.
[14] C. Watson,et al. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] S. Carreau,et al. Testicular Estrogens and Male Reproduction. , 2000, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[16] Jianying Hu,et al. Products of aqueous chlorination of 4‐nonylphenol and their estrogenic activity , 2002, Environmental toxicology and chemistry.
[17] Christina M. Morris,et al. Dopaminergic polymorphisms in Tourette syndrome: Association with the DAT gene (SLC6A3) , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[18] Michigan.,et al. Toxicological profile for dichloropropenes , 2008 .
[19] J. Hassan,et al. Phytoestrogens levels determination in the cord blood from Malaysia rural and urban populations. , 2007, Toxicology and applied pharmacology.
[20] T. Robbins,et al. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson’s disease , 2005, Journal of Neurology.
[21] Jun Wang,et al. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. , 1998, Carcinogenesis.
[22] L. Howells,et al. Indole-3-carbinol enhances anti-proliferative, but not anti-invasive effects of oxaliplatin in colorectal cancer cell lines. , 2008, Biochemical pharmacology.
[23] P. Thomas,et al. Disruption of rapid, nongenomic steroid actions by environmental chemicals: interference with progestin stimulation of sperm motility in Atlantic croaker. , 2004, Environmental science & technology.
[24] B. Vanderhyden,et al. A new, nongenomic estrogen action: the rapid release of intracellular calcium. , 1992, Endocrinology.
[25] Y. Shimohigashi,et al. Structural requirements of para-alkylphenols to bind to estrogen receptor. , 1999, European journal of biochemistry.
[26] D. Edwards,et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. , 2001, Molecular cell.
[27] P. Shaul,et al. Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae , 2002, Steroids.
[28] M Carlquist,et al. Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.
[29] R. Alyea,et al. Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux , 2009, BMC Neuroscience.
[30] S. Simons. What goes on behind closed doors: physiological versus pharmacological steroid hormone actions , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.
[31] I. Raskin,et al. Dietary phytoestrogens and health. , 2004, Phytochemistry.
[32] R. Alyea,et al. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues , 2007, Molecular and Cellular Endocrinology.
[33] M. Dudley,et al. Environmental estrogens induce transcriptionally active estrogen receptor dimers in yeast: activity potentiated by the coactivator RIP140. , 1999, Environmental health perspectives.
[34] T. Collins,et al. Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin , 1994 .
[35] J. Richie,et al. Caveolin-1 Interacts with Androgen Receptor , 2001, The Journal of Biological Chemistry.
[36] R. Santen,et al. Estrogen rapid action via protein complex formation involving ERα and Src , 2005, Trends in Endocrinology & Metabolism.
[37] W. Foster,et al. Rapid effects of pesticides on human granulosa-lutein cells. , 2006, Reproduction.
[38] Kristina A Thayer,et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.
[39] C. Watson,et al. Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells , 2004, Breast Cancer Research.
[40] D. Barceló,et al. Occurrence and removal of estrogenic short-chain ethoxy nonylphenolic compounds and their halogenated derivatives during drinking water production. , 2003, Environmental science & technology.
[41] D. Singleton,et al. Xenoestrogen exposure and mechanisms of endocrine disruption. , 2003, Frontiers in bioscience : a journal and virtual library.
[42] J. Jameson,et al. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] F. Greenspan. Basic and Clinical Endocrinology , 1990 .
[44] Frederick S vom Saal,et al. Components of plastic: experimental studies in animals and relevance for human health , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.
[45] L. Schuler,et al. Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. , 2003, Oncogene.
[46] E. Bickoff,et al. Coumestrol, a new estrogen isolated from forage crops. , 1957, Science.
[47] T. Colborn,et al. Neurodevelopment and Endocrine Disruption , 2003, Environmental health perspectives.
[48] T. Mabry,et al. Flavonoid effects relevant to cancer. , 2002, The Journal of nutrition.
[49] S. Swan,et al. Bisphenol A Data in NHANES Suggest Longer than Expected Half-Life, Substantial Nonfood Exposure, or Both , 2009, Environmental health perspectives.
[50] D. Naiman,et al. Bisphenol A (BPA) daily intakes in the United States: Estimates from the 2003–2004 NHANES urinary BPA data , 2008, Journal of Exposure Science and Environmental Epidemiology.
[51] C. Watson,et al. Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases , 2009, BMC Cancer.
[52] D. Schaid,et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study , 2001, Movement disorders : official journal of the Movement Disorder Society.
[53] J. Farrar,et al. Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors , 2009, Cancer.
[54] Adrian V. Lee,et al. Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells , 2004, Molecular and Cellular Endocrinology.
[55] M. Reinhard,et al. Occurrence and fate of pharmaceuticals and alkylphenol ethoxylate metabolites in an effluent‐dominated river and wetland , 2004, Environmental toxicology and chemistry.
[56] B S Peterson,et al. Pathogenesis of Tourette's syndrome. , 1997, Journal of child psychology and psychiatry, and allied disciplines.
[57] E. Thurman,et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .
[58] M. Benahmed,et al. Low Doses of Bisphenol A Promote Human Seminoma Cell Proliferation by Activating PKA and PKG via a Membrane G-Protein–Coupled Estrogen Receptor , 2009, Environmental health perspectives.
[59] J. Sumpter,et al. Structural Features of Alkylphenolic Chemicals Associated with Estrogenic Activity* , 1997, The Journal of Biological Chemistry.
[60] L. Schuler,et al. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor α and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[61] M. Bagchi,et al. Recruitment of Distinct Chromatin-modifying Complexes by Tamoxifen-complexed Estrogen Receptor at Natural Target Gene Promoters in Vivo* , 2004, Journal of Biological Chemistry.
[62] B. Katzenellenbogen,et al. The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC‐12 cells , 2008, Journal of neurochemistry.
[63] O. Kwon,et al. COMPARATIVE EVALUATION OF ALKYLPHENOLIC COMPOUNDS ON ESTROGENIC ACTIVITY IN VITRO AND IN VIVO , 2002, Journal of toxicology and environmental health. Part A.
[64] R. Santen,et al. Estrogen rapid action via protein complex formation involving ERalpha and Src. , 2005, Trends in endocrinology and metabolism: TEM.
[65] B R Christopher,et al. FIFTEEN YEARS AFTER , 1999 .
[66] D. Gorenstein,et al. Structure and dynamics of cytochrome c in nonaqueous solvents by 2D NH-exchange NMR spectroscopy , 1993 .
[67] C. Portier,et al. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. , 1997, Toxicology and applied pharmacology.
[68] I. Quesada,et al. The pancreatic β-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes , 2009, Molecular and Cellular Endocrinology.
[69] J. Sellés,et al. Novel action of estrone on vascular tissue: regulation of NOS and COX activity , 2005, Steroids.
[70] Cheryl S Watson,et al. Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses , 2004, Breast Cancer Research.
[71] H. Matsushita,et al. Identification and quantification of chlorinated bisphenol A in wastewater from wastepaper recycling plants. , 2001, Chemosphere.
[72] J. Oehlmann,et al. Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response , 2005, Human & experimental toxicology.
[73] C. Otto,et al. In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[74] H. Adlercreutz,et al. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. , 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[75] J. Corton,et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.
[76] R. Alyea,et al. Differential Regulation of Dopamine Transporter Function and Location by Low Concentrations of Environmental Estrogens and 17β-Estradiol , 2009, Environmental health perspectives.
[77] R McKinlay,et al. Calculating human exposure to endocrine disrupting pesticides via agricultural and non-agricultural exposure routes. , 2008, The Science of the total environment.
[78] C. Watson,et al. Alkylphenol Xenoestrogens with Varying Carbon Chain Lengths Differentially and Potently Activate Signaling and Functional Responses in GH3/B6/F10 Somatomammotropes , 2008, Environmental health perspectives.
[79] L. Schuler,et al. Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice , 2003, Oncogene.
[80] R. Habert,et al. Estrogen effects on fetal and neonatal testicular development. , 2006, Reproduction.
[81] G. Litwack. Biochemical Actions of Hormones , 2012 .
[82] J. Gorski,et al. Estrogens and the genetic control of tumor growth. , 1997, Progress in clinical and biological research.
[83] A. Norman,et al. A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. , 2002, Biochemical and biophysical research communications.
[84] C. Watson,et al. Xenoestrogens at Picomolar to Nanomolar Concentrations Trigger Membrane Estrogen Receptor-α–Mediated Ca2+ Fluxes and Prolactin Release in GH3/B6 Pituitary Tumor Cells , 2005, Environmental health perspectives.
[85] Eric R. Prossnitz,et al. A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.
[86] D. Dluzen,et al. Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system , 2005, Pharmacology Biochemistry and Behavior.
[87] S. Deventer,et al. A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. , 2000, The Biochemical journal.
[88] R. Kurlan. The pathogenesis of Tourette's syndrome. A possible role for hormonal and excitatory neurotransmitter influences in brain development. , 1992, Archives of neurology.
[89] Gerald T Ankley,et al. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[90] P. Whitten,et al. Cross-species and interassay comparisons of phytoestrogen action. , 2001, Environmental health perspectives.
[91] T. Walle,et al. HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.
[92] R. Einspanier,et al. Amphibians as a model to study endocrine disruptors: II. Estrogenic activity of environmental chemicals in vitro and in vivo. , 1999, The Science of the total environment.
[93] F. B. Davis,et al. Effects of Resin or Charcoal Treatment on Fetal Bovine Serum and Bovine Calf Serum , 2009, Endocrine research.
[94] H. Adlercreutz. Phytoestrogens: epidemiology and a possible role in cancer protection. , 1995, Environmental health perspectives.
[95] J. Croué,et al. Chlorination of bisphenol A: kinetics and by-products formation. , 2004, Chemosphere.
[96] C. Watson,et al. Xenoestrogen-Induced ERK-1 and ERK-2 Activation via Multiple Membrane-Initiated Signaling Pathways , 2004, Environmental health perspectives.
[97] D. Kolpin,et al. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams , 2005 .
[98] J. Corton,et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.
[99] L. Gooren,et al. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. , 2008, European journal of endocrinology.
[100] P. Quinn. Treating adolescent girls and women with ADHD: gender-specific issues. , 2005, Journal of clinical psychology.
[101] S. Hankinson,et al. The role of prolactin in mammary carcinoma. , 2003, Endocrine reviews.
[102] C. Watson,et al. Membrane estrogen receptor-α-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells , 2009, Journal of molecular signaling.
[103] M. Michel,et al. Ligand-Directed Signaling: 50 Ways to Find a Lover , 2007, Molecular Pharmacology.
[104] E. Stefani,et al. Pancreatic Insulin Content Regulation by the Estrogen Receptor ERα , 2008, PloS one.
[105] J. Westendorf,et al. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. , 2001, Toxicology.
[106] O. Jänne,et al. Differential sensitivity of specific genes in mouse kidney to androgens and antiandrogens , 1985 .
[107] R. Bigsby,et al. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. , 1997, Endocrinology.
[108] S. Shenhav,et al. Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome , 2003, Acta obstetricia et gynecologica Scandinavica.
[109] John Peterson Myers,et al. A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health , 2009, Environmental health perspectives.